G1 Therapeutics (GTHX) Tops Q2 Earnings and Revenue Estimates

This article was originally published on Nasdaq

G1 Therapeutics (GTHX) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of a loss of $0.17 per share. This compares to loss of $0.92 per share a year ago. These figures are adjusted for non